Author

S. K. Das Majumdar

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Assay:proteomics· 1 Organism:zebrafish· 1

Frequent Co-Authors

O. Shriwas· 2 shared P. Mohapatra· 2 shared R. Dash· 2 shared R. Rath· 2 shared S. A. Ansari· 2 shared S. Mohanty· 2 shared A. Ghosh· 1 shared M. Priyadarshini· 1 shared

Activity by Year

2021-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 41 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

O. Shriwas

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintApr 8, 2022

CMTM6 mediates cisplatin resistance in OSCC by regulating AKT/c-MYC driven ribosome biogenesis

P. Mohapatra, S. Mohanty, S. A. Ansari…·R. Dash

This study identifies CMTM6 as a regulator of ribosome biogenesis in cisplatin-resistant OSCC, showing that targeting this pathway can restore chemosensitivity.

DOI 10.1101/2022.04.08.487634

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivAug 19, 2021

CRISPR-based kinome-screening revealed MINK1 as a druggable player to rewire 5FU-resistance in OSCC through AKT/MDM2/p53 axis

S. Mohanty, P. Mohapatra, O. Shriwas…·R. Dash

The paper identifies MINK1 as a key driver of 5FU resistance in OSCC using CRISPR screening and shows that lestaurtinib can restore 5FU sensitivity.

DOI 10.1038/s41388-022-02475-8

humanzebrafish

𝕏 PostBluesky